Patent application number | Description | Published |
20090017116 | EXTENDED RELEASE GLICLAZIDE FORMULATIONS - The present invention relates to an extended release (XL) pharmaceutical tablet composition for oral administration and methods of its manufacture. More particularly, the present invention relates to an extended release gliclazide formulation which does not increase the blood glucose level in human patients. | 01-15-2009 |
20090175938 | Controlled Release Flurbiprofen and Muscle Relaxant Combinations - This invention is a novel controlled release (CR) flurbiprofen and muscle relaxant combinations for oral administration with anti-inflammatory, analgesic, myorelaxant activity and methods of its manufacture. The pharmaceutical composition of the present invention is administered orally in tablet, multilayer tablet, multicoated tablet and capsule form. | 07-09-2009 |
20100234342 | EZETIMIBE COMPOSITIONS - This invention is a novel pharmaceutical composition of ezetimibe or a pharmaceutically acceptable salt thereof comprising one or more pharmaceutically acceptable excipients having high bioavailability with improved solubility and dissolution rate which is stable throughout the shelflife, methods for their preparation, and methods for treatment using the same. | 09-16-2010 |
20100272800 | ORALLY DISINTEGRATING OLANZAPINE TABLET - According to the present invention an orally disintegrating olanzapine tablet comprising magnesium stearate and sodium stearyl fumarate and one or more phramaceutically acceptable excipient in which the total weight of magnesium stearate and sodium stearyl fumarate is about 0.1 to 5% by weight of the total tablet and wherein the tablet disintegrates within up to 90 seconds in oral cavity is provided. | 10-28-2010 |
20110053877 | NIMESULIDE AND MUSCLE RELAXANT COMBINATIONS THEREOF - A topical pharmaceutical formulation made up of nimesulide or a pharmaceutically acceptable derivative of nimesulide, together with thiocolchicoside or a pharmaceutically acceptable derivative of thiocolchicoside. The present invention more particularly relates to pharmaceutical combinations of nimesulide and thiocolchicoside, in the form of topical gels, ointments, cream, sprays, or lotions with anti-inflammatory, analgesic, and myorelaxant activities. | 03-03-2011 |
20110071098 | FLURBIPROFEN AND MUSCLE RELAXANT GEL COMBINATIONS THEREOF - A topical pharmaceutical gel includes flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, thiocolchicoside or a pharmaceutically acceptable salt of thiocolchicoside, and menthol. Pharmaceutical combinations of flurbiprofen, thiocolchicoside, and menthol in the form of topical gels with anti-inflammatory, analgesic, and myorelaxant activities are described. | 03-24-2011 |
20110223245 | CONTROLLED-RELEASE FORMULATIONS OF PRAMIPEXOLE - A controlled-release pharmaceutical formulation, comprising pramipexole or a pharmaceutically acceptable salt of pramipexole, colloidal silicone dioxide, and glyceryl behenate. | 09-15-2011 |
20110236473 | STABLE ALISKIREN FORMULATIONS - An oral pharmaceutical formulation, made up of croscarmellose sodium and internal granules including a pharmaceutically acceptable salt or polymorph of aliskiren and stearic acid. | 09-29-2011 |
20110257159 | ORALLY DISINTEGRATING TABLET FORMULATIONS OF MIRTAZAPINE AND PROCESS FOR PREPARING THE SAME - Silicon dioxide free orally disintegrating tablet formulations of mirtazapine or a pharmaceutically acceptable salt thereof having crospovidone and sodium stearyl fumarate and one or more pharmaceutically acceptable excipients and a process for preparing such a formulation. | 10-20-2011 |
20110268797 | MULTICOATED ALISKIREN FORMULATIONS - An oral pharmaceutical formulation of aliskiren, or a pharmaceutically acceptable salt or polymorph thereof, having at least two coating layers. | 11-03-2011 |
20110274751 | TRIMETAZIDINE FORMULATION WITH DIFFERENT RELEASE PROFILES - A multilayered solid oral pharmaceutical formulation of trimetazidine or a pharmaceutically acceptable salt or polymorph of trimetazidine wherein one layer of said formulation provides controlled release, while the other layer provides immediate release. | 11-10-2011 |
20110274752 | MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF DEXLANSOPRAZOLE - Modified release oral pharmaceutical compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof in the form of a bilayer tablet and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders. | 11-10-2011 |
20110274753 | DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE - Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders. | 11-10-2011 |
20110274754 | ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE - Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders. | 11-10-2011 |
20110288138 | ORALLY DISINTEGRATING TABLETS OF ZOLMITRIPTAN AND PROCESS FOR PREPARING THE SAME - Silicon dioxide free orally disintegrating tablet formulations of zolmitriptan or a pharmaceutically acceptable salt thereof having magnesium carbonate heavy and sodium stearyl fumarate with one or more pharmaceutically acceptable excipients and a process for preparing such a formulation and its use in the treatment of migraines. | 11-24-2011 |
20110294885 | CONTROLLED-RELEASE PREGABALIN COMPOSITIONS - An orally-administrable controlled-release formulation, including pregabalin or a pharmaceutically acceptable salt of pregabalin and polycarbophil, as a controlled-release agent. | 12-01-2011 |
20110294886 | CONTROLLED-RELEASE TABLET FORMULATIONS OF PREGABALIN - A controlled-release tablet formulation which gels in the stomach, including pregabalin or a pharmaceutically acceptable salt thereof, and a complex of sodium alginate and calcium chloride, or calcium alginate, or a properly-proportioned mixture thereof as a controlled-release agent. | 12-01-2011 |
20110294887 | CONTROLLED-RELEASE SOLUTION FORMULATIONS OF PREGABALIN - A controlled-release oral solution formulation, which gels in the stomach, includes pregabalin or a pharmaceutically acceptable salt of pregabalin and a gelling agent. | 12-01-2011 |
20110305757 | NEW PHARMACEUTICAL COMBINATIONS - A pharmaceutical composition including a compound of Formula I (Compound I) or pharmaceutically acceptable salts thereof and one or more diuretics as effective components, wherein said one or more diuretics are selected from thiazide derivatives. Methods for preparing the pharmaceutical compound including Compound I and thiazide derivatives and its use for preventing or treating hypertension in mammals, particularly in humans. | 12-15-2011 |
20140023709 | ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE - Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders. | 01-23-2014 |
20140030328 | DUAL RELEASE ORAL TABLET COMPOSITIONS OF DEXLANSOPRAZOLE - Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders. | 01-30-2014 |
20140302150 | DPP-IV INHIBITOR FORMULATIONS - The present invention relates to a pharmaceutical formulation, characterized by comprising a DPP-IV inhibitor and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer. | 10-09-2014 |
20140308348 | FLURBIPROFEN AND MUSCLE RELAXANT COMBINATIONS - This invention is a novel pharmaceutical composition comprising flurbiprofen or a pharmaceutically acceptable salt thereof in combination with an α-2 adrenergic receptor agonist or a gamma-aminobutiric acid receptor agonist with anti-inflammatory, analgesic and myorelaxant activity. | 10-16-2014 |
20140315843 | TOPICAL PHARMACEUTICAL COMPOSITIONS OF THIOCOLCHICOSIDE AND METHYLSULFONYLMETHANE - The present invention relates to a topical pharmaceutical composition of thiocolchicoside and methylsulfonylmethane comprising at least one penetration enhancer and one or more gelling agent. Furthermore, the invention relates to process for preparing the said topical pharmaceutical composition and its use for the treatment of pain and inflammatory symptoms associated with muscle-skeletal system and osteoarthritis. | 10-23-2014 |
20140322338 | FLURBIPROFEN FORMULATIONS - This invention relates to a pharmaceutical formulation, characterized by comprising flurbiprofen and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer. | 10-30-2014 |
20140336148 | COMBINATIONS OF DIACEREIN AND NON-STEROIDAL INFLAMMATION DRUGS - The present invention relates to novel pharmaceutical combinations with synergistic action of diacerein or a pharmaceutically acceptable salt of diacerein and non-steroidal inflammatory drugs, having analgesic, anti-inflammatory, antipyretic, and osteoarthritis-treating activities. | 11-13-2014 |
20140363508 | PHARMACEUTICAL FORMULATIONS OF FLURBIPROFEN AND GLUCOSAMIN - The present invention relates to pharmaceutical formulations of flurbiprofen or a pharmaceutically acceptable salt thereof and glucosamine or salts thereof. Particularly, the present invention relates to a stable formulation of this combination having desired levels of dissolution rate and solubility which comprises at least one polymer having a low glass transition temperature. | 12-11-2014 |
20140371318 | ORALLY-DISINTEGRATING FORMULATIONS OF FLURBIPROFEN - The present invention relates to an orally-disintegrating pharmaceutical formulation, which is characterized by comprising flurbiprofen and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer. | 12-18-2014 |
20140377343 | FORMULATIONS OF FLURBIPROFEN AND DIACEREIN - The present invention relates to a pharmaceutical formulation, characterized by comprising flurbiprofen or a pharmaceutically acceptable salt of flurbiprofen, diacerein or a pharmaceutically acceptable salt of diacerein, as well as at least one or a properly-proportioned mixture of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer or polyvinyl alcohol-polyethylene glycol copolymer. | 12-25-2014 |
20140377350 | BILAYER TABLET FORMULATIONS OF FLURBIPROFEN AND GLUCOSAMIN - Bilayer Tablet Formulations of Flurbiprofen And Glucosamin The present invention relates to a bilayer tablet formulation of flurbiprofen and glucosamine. Particularly, the present invention relates to a bilayer tablet formulation having a controlled release flurbiprofen and immediate release glucosamine; furthermore relates to their process and use. | 12-25-2014 |